USE OF MSCT EXAMINATION IN DIFFUSE LIVER DISEASES

Authors

  • Akramxon Sharipov Students of Tashkent Medical Academy Author
  • Umida Raxmonova Students of Tashkent Medical Academy Author
  • Vinayak Koli Students of Tashkent Medical Academy Author
  • Dwivedi Kalash Students of Tashkent Medical Academy Author

Abstract

More than 350 million people worldwide are infected with hepatitis viruses. Each year, millions of people are newly infected with viruses causing liver diseases, including hepatitis B and hepatitis C, leading to life-threatening conditions. Liver cirrhosis and hepatocellular carcinoma are consequences of chronic hepatitis B and C infections.

References

"Hepatitis C: The Silent Epidemic" by Lucinda K. Porter

"Hepatitis B and C: Management and Treatment" by Geoffrey Dusheiko

"Hepatitis C: A Complete Guide for Patients and Families" by Paul J. Thuluvath

"Hepatitis Viruses: Molecular Biology and Pathogenesis" by Seng-Lai Tan

"Hepatitis C Virus: From Molecular Virology to Antiviral Therapy" by Ralf Bartenschlager and Charles M. Rice

Published

2024-04-22

Issue

Vol. 2 No. 10 (2024): Молодые ученые

Section

Articles

How to Cite

USE OF MSCT EXAMINATION IN DIFFUSE LIVER DISEASES. (2024). Young Scientists, 2(10), 114-121. https://in-academy.uz/index.php/YO/article/view/27682